Inventor

SCARIA ABRAHAM

US29 patents

⚠️ This page may combine multiple inventors who share the name “SCARIA ABRAHAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCARIA ABRAHAM

GENZYME CORP

Adenoviral vectors capable of facilitating increased persistence of transgene expression

Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products

Multimeric constructs

Methods for treating blood coagulation disorders

Nucleic acids encoding fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof

Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof

AAV vectors for retinal and CNS gene therapy

Compositions and methods for treating and preventing macular degeneration

Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products

Enhanced anti-tumor immunity

Multimeric constructs

Compositions and methods for treating and preventing macular degeneration

AAV vectors for retinal and CNS gene therapy

Use of iNOS inhibitors to increase viral yield in culture

Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof

Compositions and methods for treating and preventing macular degeneration

Adeno-associated viral vectors for treating myocilin (MYOC) glaucoma

Gene editing of deep intronic mutations

CRISPR THERAPEUTICS AG

Materials and methods for treatment of autosomal dominant retinitis pigmentosa

Materials and methods for treatment of usher syndrome type 2A

Materials and methods for treatment of usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)

Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)

Materials and methods for treatment of usher syndrome type 2A

Materials and methods for treatment of autosomal dominant retinitis pigmentosa

Materials and methods for treatment of autosomal dominant cone-rod dystrophy

Materials and methods for controlling gene editing

SCARIA ABRAHAM

Multimeric constructs

Fusion proteins and methods for inhibiting IL-17 pathways

ATKINSON MARK A

Combination therapies for treating type 1 diabetes